QIAGEN Shares Outstanding 2010-2023 | QGEN

QIAGEN shares outstanding history from 2010 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • QIAGEN shares outstanding for the quarter ending September 30, 2023 were 0.228B, a 0.22% increase year-over-year.
  • QIAGEN 2022 shares outstanding were 0.23B, a 0.82% decline from 2021.
  • QIAGEN 2021 shares outstanding were 0.232B, a 0.93% decline from 2020.
  • QIAGEN 2020 shares outstanding were 0.234B, a 3.28% increase from 2019.
QIAGEN Annual Shares Outstanding
(Millions of Shares)
2022 230
2021 232
2020 234
2019 227
2018 233
2017 233
2016 239
2015 239
2014 243
2013 233
2012 232
2011 230
2010 232
2009 206
QIAGEN Quarterly Shares Outstanding
(Millions of Shares)
2023-09-30 228
2023-06-30 231
2023-03-31 231
2022-12-31 230
2022-09-30 228
2022-06-30 230
2022-03-31 230
2021-12-31 232
2021-09-30 232
2021-06-30 232
2021-03-31 231
2020-12-31 234
2020-09-30 236
2020-06-30 234
2020-03-31 232
2019-12-31 227
2019-09-30 227
2019-06-30 233
2019-03-31 234
2018-12-31 233
2018-09-30 235
2018-06-30 234
2018-03-31 233
2017-12-31 233
2017-09-30 233
2017-06-30 233
2017-03-31 235
2016-12-31 239
2016-09-30 239
2016-06-30 239
2016-03-31 238
2015-12-31 239
2015-09-30 228
2015-06-30 228
2015-03-31 229
2014-12-31 243
2014-09-30 232
2014-06-30 232
2014-03-31 234
2013-12-31 233
2013-09-30 233
2013-06-30 225
2013-03-31 233
2012-12-31 232
2012-09-30 233
2012-06-30 231
2012-03-31 230
2011-12-31 230
2011-09-30 229
2011-06-30 232
2011-03-31 231
2010-12-31 231
2010-09-30 230
2010-06-30 233
2010-03-31 227
2009-12-31 232
2009-09-30 201
2009-06-30 196
2009-03-31 196
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $9.384B $2.142B
QIAGEN N.V. is one of the world's leading providers of technologies and products for the separation, purification and handling of nucleic acids DNA/RNA. The company provides innovative technologies and products for pre-analytical sample preparation and molecular diagnostics solutions. It has developed a comprehensive portfolio of proprietary, consumable products, and automated solutions for sample collection. Qiagen has subsidiaries several other countries with good sales potential. Segment Details Consumables: These are typically sample preparation or test kits that contain all the necessary reagents and buffers, and a manual including protocols and relevant background information. Automated Instruments: These automate the use of Sample & Assay Technologies into efficient solutions for a broad range of laboratory needs. Customer Classes: QIAGEN focuses on 4 principal segments or customer classes for sample and assay technologies:? Molecular Diagnostics, Applied Testing, Pharma and Academia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $144.305B 14.95
Bristol Myers Squibb (BMY) United States $100.476B 6.48
Gilead Sciences (GILD) United States $95.447B 11.48
Vertex Pharmaceuticals (VRTX) United States $91.429B 26.88
Regeneron Pharmaceuticals (REGN) United States $89.752B 21.48
CSL (CSLLY) Australia $83.812B 0.00
GSK (GSK) United Kingdom $73.690B 9.55
Seagen (SGEN) United States $40.019B 0.00
Biogen (BIIB) United States $33.918B 14.79
Moderna (MRNA) United States $29.626B 0.00
Argenex SE (ARGX) Netherlands $26.621B 0.00
BioNTech SE (BNTX) Germany $23.869B 8.71
Alnylam Pharmaceuticals (ALNY) United States $21.114B 0.00
Genmab (GMAB) Denmark $20.884B 33.63
BeiGene (BGNE) Cayman Islands $17.806B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.157B 82.80
Illumina (ILMN) United States $16.190B 117.18
Incyte (INCY) United States $12.177B 23.63
Exact Sciences (EXAS) United States $11.574B 0.00
Legend Biotech (LEGN) United States $11.056B 0.00
Bio-Techne Corp (TECH) United States $9.948B 35.74
Sino Biopharmaceutical (SBMFF) Hong Kong, SAR China $9.307B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.944B 25.61
Repligen (RGEN) United States $8.780B 75.60
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.594B 0.00
Roivant Sciences (ROIV) United Kingdom $7.685B 0.00
Sarepta Therapeutics (SRPT) United States $7.603B 0.00
Karuna Therapeutics (KRTX) United States $7.214B 0.00
Exelixis (EXEL) United States $6.782B 77.89
Apellis Pharmaceuticals (APLS) United States $6.384B 0.00
Swedish Orphan Biovitrum (BIOVF) Sweden $6.213B 21.93
Intra-Cellular Therapies (ITCI) United States $5.906B 0.00
Ascendis Pharma (ASND) Denmark $5.791B 0.00
Immunovant (IMVT) United States $5.661B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.301B 0.00
Halozyme Therapeutics (HALO) United States $5.100B 17.24
Vaxcyte (PCVX) United States $4.926B 0.00
Blueprint Medicines (BPMC) United States $4.233B 0.00
Nuvalent (NUVL) United States $4.094B 0.00
Alkermes (ALKS) Ireland $4.029B 31.76
Mirati Therapeutics (MRTX) United States $3.981B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.658B 0.00
Insmed (INSM) United States $3.579B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.359B 0.00
Cytokinetics (CYTK) United States $3.283B 0.00
Amicus Therapeutics (FOLD) United States $3.232B 0.00
Axsome Therapeutics (AXSM) United States $3.192B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.190B 0.00
Guardant Health (GH) United States $2.970B 0.00
Krystal Biotech (KRYS) United States $2.940B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.742B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.733B 0.00
Zai Lab (ZLAB) China $2.697B 0.00
Biohaven (BHVN) United States $2.673B 0.00
Intellia Therapeutics (NTLA) United States $2.654B 0.00
Fortrea Holdings (FTRE) United States $2.614B 0.00
Structure Therapeutics (GPCR) United States $2.583B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.581B 0.00
Denali Therapeutics (DNLI) United States $2.559B 0.00
Arcellx (ACLX) United States $2.557B 0.00
Zealand Pharma (ZLDPF) Denmark $2.547B 0.00
Galapagos (GLPG) Belgium $2.467B 0.00
ImmunityBio (IBRX) United States $2.457B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.393B 0.00
NeoGenomics (NEO) United States $2.316B 0.00
Certara (CERT) United States $2.303B 38.95
Beam Therapeutics (BEAM) United States $2.289B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.103B 0.00
IDEAYA Biosciences (IDYA) United States $2.027B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.976B 0.00
SpringWorks Therapeutics (SWTX) United States $1.902B 0.00
Bavarian Nordic (BVNRY) Denmark $1.896B 11.42
Neumora Therapeutics (NMRA) United States $1.871B 0.00
Dynavax Technologies (DVAX) United States $1.771B 35.13
Prothena (PRTA) Ireland $1.748B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.702B 10.84
Vericel (VCEL) United States $1.696B 0.00
Myriad Genetics (MYGN) United States $1.569B 0.00
Iovance Biotherapeutics (IOVA) United States $1.553B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.495B 0.00
POINT Biopharma Global (PNT) United States $1.449B 15.11
RayzeBio (RYZB) United States $1.431B 0.00
Merus (MRUS) Netherlands $1.428B 0.00
Celldex Therapeutics (CLDX) United States $1.428B 0.00
Twist Bioscience (TWST) United States $1.387B 0.00
AbCellera Biologics (ABCL) Canada $1.367B 0.00
Disc Medicine (IRON) United States $1.332B 0.00
Vir Biotechnology (VIR) United States $1.277B 0.00
Viking Therapeutics (VKTX) United States $1.222B 0.00
Arvinas (ARVN) United States $1.209B 0.00
CureVac (CVAC) Germany $1.209B 0.00
Morphic Holding (MORF) United States $1.179B 0.00
Belite Bio (BLTE) United States $1.161B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.159B 0.00
Kymera Therapeutics (KYMR) United States $1.152B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.137B 0.00
Arcus Biosciences (RCUS) United States $1.127B 0.00
Protagonist Therapeutics (PTGX) United States $1.050B 0.00
Geron (GERN) United States $1.048B 0.00
ANI Pharmaceuticals (ANIP) United States $1.018B 13.57
Ligand Pharmaceuticals (LGND) United States $1.012B 16.61
Deciphera Pharmaceuticals (DCPH) United States $1.010B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.008B 0.00
Apogee Therapeutics (APGE) United States $0.989B 0.00
Inhibrx (INBX) United States $0.982B 0.00
MannKind (MNKD) United States $0.976B 0.00
Cytek Biosciences (CTKB) United States $0.941B 0.00
Akero Therapeutics (AKRO) United States $0.933B 0.00
Keros Therapeutics (KROS) United States $0.909B 0.00
Scholar Rock Holding (SRRK) United States $0.908B 0.00
MiMedx (MDXG) United States $0.904B 0.00
Northwest Biotherapeutics (NWBO) United States $0.881B 0.00
Viridian Therapeutics (VRDN) United States $0.880B 0.00
Editas Medicine (EDIT) United States $0.860B 0.00
REGENXBIO (RGNX) United States $0.859B 0.00
ADMA Biologics Inc (ADMA) United States $0.836B 0.00
Pliant Therapeutics (PLRX) United States $0.832B 0.00
Sana Biotechnology (SANA) United States $0.800B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.796B 0.00
Tango Therapeutics (TNGX) United States $0.775B 0.00
Pharming Group (PHAR) Netherlands $0.773B 0.00
Olema Pharmaceuticals (OLMA) United States $0.764B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.744B 0.00
Pharming Group (PHGUF) Netherlands $0.744B 0.00
Ambrx Biopharma (AMAM) United States $0.729B 0.00
Kura Oncology (KURA) United States $0.718B 0.00
Prime Medicine (PRME) United States $0.707B 0.00
Cabaletta Bio (CABA) United States $0.688B 0.00
Immatics (IMTX) Germany $0.678B 0.00
HilleVax (HLVX) United States $0.664B 0.00
Cogent Biosciences (COGT) United States $0.661B 0.00
Replimune (REPL) United States $0.660B 0.00
ACELYRIN, INC (SLRN) United States $0.654B 0.00
Novavax (NVAX) United States $0.653B 0.00
Pharma Mar (PHMMF) Spain $0.645B 0.00
Sinovac Biotech (SVA) China $0.644B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.640B 9.14
Adaptive Biotechnologies (ADPT) United States $0.634B 0.00
Zymeworks (ZYME) United States $0.621B 2.85
89BIO (ETNB) United States $0.608B 0.00
Vera Therapeutics (VERA) United States $0.602B 0.00
Revance Therapeutics (RVNC) United States $0.595B 0.00
Anavex Life Sciences (AVXL) United States $0.592B 0.00
Avidity Biosciences (RNA) United States $0.579B 0.00
CARGO Therapeutics (CRGX) $0.578B 0.00
Tarsus Pharmaceuticals (TARS) United States $0.547B 0.00
PureTech Health (PRTC) United States $0.545B 0.00
Biomea Fusion (BMEA) United States $0.538B 0.00
Castle Biosciences (CSTL) United States $0.538B 0.00
WAVE Life Sciences (WVE) Singapore $0.526B 0.00
AN2 Therapeutics (ANTX) United States $0.523B 0.00
Caribou Biosciences (CRBU) United States $0.519B 0.00
Icosavax (ICVX) United States $0.507B 0.00
Tyra Biosciences (TYRA) United States $0.504B 0.00
Rapt Therapeutics (RAPT) United States $0.499B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.497B 0.00
MaxCyte (MXCT) United States $0.492B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.486B 0.00
Travere Therapeutics (TVTX) United States $0.472B 0.00
Liquidia Technologies (LQDA) United States $0.465B 0.00
Alector (ALEC) United States $0.456B 0.00
LianBio (LIAN) United States $0.437B 0.00
Aerovate Therapeutics (AVTE) United States $0.435B 0.00
Entrada Therapeutics (TRDA) United States $0.433B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.433B 0.00
Oric Pharmaceuticals (ORIC) United States $0.431B 0.00
Bluebird Bio (BLUE) United States $0.418B 0.00
23andMe Holding (ME) United States $0.412B 0.00
Adlai Nortye (ANL) Cayman Islands $0.406B 0.00
Janux Therapeutics (JANX) United States $0.403B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.400B 0.00
Allogene Therapeutics (ALLO) United States $0.395B 0.00
IGM Biosciences (IGMS) United States $0.394B 0.00
ALX Oncology Holdings (ALXO) United States $0.391B 0.00
Edgewise Therapeutics (EWTX) United States $0.386B 0.00
AnaptysBio (ANAB) United States $0.376B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.369B 0.00
Oculis Holding AG (OCS) Switzerland $0.358B 0.00
Celcuity (CELC) United States $0.355B 0.00
Gracell Biotechnologies (GRCL) China $0.354B 0.00
Cullinan Oncology (CGEM) United States $0.350B 0.00
Arbutus Biopharma (ABUS) United States $0.344B 0.00
Nautilus Biotechnology (NAUT) United States $0.344B 0.00
Third Harmonic Bio (THRD) United States $0.343B 0.00
ITeos Therapeutics (ITOS) United States $0.335B 0.00
MeiraGTx Holdings (MGTX) United States $0.332B 0.00
UniQure (QURE) Netherlands $0.324B 0.00
Avid Bioservices (CDMO) United States $0.321B 0.00
Anika Therapeutics (ANIK) United States $0.321B 0.00
Voyager Therapeutics (VYGR) United States $0.319B 5.90
Immunome (IMNM) United States $0.319B 0.00
Genelux (GNLX) United States $0.318B 0.00
Amarin (AMRN) Ireland $0.316B 0.00
TScan Therapeutics (TCRX) United States $0.312B 0.00
Urogen Pharma (URGN) United States $0.309B 0.00
Aura Biosciences (AURA) United States $0.307B 0.00
Nurix Therapeutics (NRIX) United States $0.302B 0.00
Fulcrum Therapeutics (FULC) United States $0.297B 0.00
Agenus (AGEN) United States $0.296B 0.00
Precigen (PGEN) United States $0.279B 0.00
AC Immune (ACIU) Switzerland $0.277B 0.00
Terns Pharmaceuticals (TERN) United States $0.275B 0.00
Humacyte (HUMA) United States $0.274B 0.00
Mineralys Therapeutics (MLYS) United States $0.274B 0.00
Nuvation Bio (NUVB) United States $0.271B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.271B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.261B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.260B 0.00
Erasca (ERAS) United States $0.257B 0.00
Poseida Therapeutics (PSTX) United States $0.255B 0.00
Atea Pharmaceuticals (AVIR) United States $0.249B 0.00
Fate Therapeutics (FATE) United States $0.246B 0.00
Inozyme Pharma (INZY) United States $0.238B 0.00
Coherus BioSciences (CHRS) United States $0.237B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.222B 0.00
Renovaro Biosciences (RENB) United States $0.222B 0.00
Mesoblast (MESO) Australia $0.221B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.221B 0.00
Lifecore Biomedical (LFCR) United States $0.217B 0.00
Inventiva S.A (IVA) France $0.217B 0.00
Repare Therapeutics (RPTX) Canada $0.217B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.216B 0.00
Akoya Biosciences (AKYA) United States $0.215B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.214B 17.71
Kamada (KMDA) Israel $0.212B 18.92
Compass Therapeutics (CMPX) United States $0.210B 0.00
Ovid Therapeutics (OVID) United States $0.210B 0.00
Cartesian Therapeutics (RNAC) United States $0.210B 0.00
Zura Bio (ZURA) United States $0.209B 0.00
Mersana Therapeutics (MRSN) United States $0.199B 0.00
ScPharmaceuticals (SCPH) United States $0.195B 0.00
Scilex Holding (SCLX) United States $0.195B 0.00
Allakos (ALLK) United States $0.194B 0.00
Innate Pharma S.A (IPHA) France $0.194B 0.00
Immuneering (IMRX) United States $0.192B 0.00
Puma Biotechnology (PBYI) United States $0.186B 48.75
Merrimack Pharmaceuticals (MACK) United States $0.181B 0.00
CorMedix Inc (CRMD) United States $0.178B 0.00
Gossamer Bio (GOSS) United States $0.176B 0.00
Prima BioMed (IMMP) Australia $0.175B 0.00
Verastem (VSTM) United States $0.174B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.174B 0.00
XOMA (XOMA) United States $0.170B 0.00
INmune Bio (INMB) United States $0.170B 0.00
Stoke Therapeutics (STOK) United States $0.169B 0.00
Astria Therapeutics (ATXS) United States $0.169B 0.00
Theseus Pharmaceuticals (THRX) United States $0.169B 0.00
Invivyd (IVVD) United States $0.168B 0.00
Dianthus Therapeutics (DNTH) United States $0.166B 0.00
Cellectis S.A (CLLS) France $0.166B 0.00
Adocia (ADOCY) France $0.166B 0.00
Codexis (CDXS) United States $0.165B 0.00
PDS Biotechnology (PDSB) United States $0.164B 0.00
Applied Therapeutics (APLT) United States $0.163B 0.00
Alimera Sciences (ALIM) United States $0.162B 0.00
GENFIT S.A (GNFT) France $0.159B 0.00
Sutro Biopharma (STRO) United States $0.159B 0.00
Praxis Precision Medicines (PRAX) United States $0.156B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.155B 0.00
Absci (ABSI) United States $0.155B 0.00
Molecular Partners AG (MOLN) Switzerland $0.153B 0.00
Greenwich LifeSciences (GLSI) United States $0.150B 0.00
Opthea (OPT) Australia $0.150B 0.00
Nuvectis Pharma (NVCT) United States $0.147B 0.00
DBV Technologies S.A (DBVT) France $0.143B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.141B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.139B 0.00
Seres Therapeutics (MCRB) United States $0.134B 0.00
Design Therapeutics (DSGN) United States $0.134B 0.00
Annexon (ANNX) United States $0.133B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.132B 0.00
Graphite Bio (GRPH) United States $0.132B 0.00
X4 Pharmaceuticals (XFOR) United States $0.130B 0.00
Nkarta (NKTX) United States $0.130B 0.00
Aadi Bioscience (AADI) United States $0.129B 0.00
I-Mab (IMAB) China $0.129B 0.00
Tenaya Therapeutics (TNYA) United States $0.128B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Ventyx Biosciences (VTYX) United States $0.128B 0.00
Kodiak Sciences (KOD) United States $0.127B 0.00
Omega Therapeutics (OMGA) United States $0.126B 0.00
Vor Biopharma (VOR) $0.125B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.125B 0.00
Oncobiologics (OTLK) United States $0.125B 0.00
Gritstone Bio (GRTS) United States $0.124B 0.00
EnGene Holdings (ENGN) United States $0.121B 0.00
XBiotech (XBIT) United States $0.119B 0.00
Abeona Therapeutics (ABEO) United States $0.119B 0.00
PepGen (PEPG) United States $0.117B 0.00
Vigil Neuroscience (VIGL) United States $0.114B 0.00
Genetron Holdings (GTH) China $0.114B 0.00
Cue Biopharma (CUE) United States $0.113B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.112B 0.00
BioXcel Therapeutics (BTAI) United States $0.111B 0.00
Emergent Biosolutions (EBS) United States $0.111B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.110B 0.00
Inovio Pharmaceuticals (INO) United States $0.108B 0.00
Vaxxinity (VAXX) United States $0.108B 0.00
Kinnate Biopharma (KNTE) United States $0.107B 0.00
Oncolytics Biotech (ONCY) Canada $0.106B 0.00
ChromaDex (CDXC) United States $0.104B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.104B 0.00
Seer (SEER) United States $0.103B 0.00
Immix Biopharma (IMMX) United States $0.102B 0.00
Ocugen (OCGN) United States $0.099B 0.00
Rani Therapeutics Holdings (RANI) United States $0.099B 0.00
G1 Therapeutics (GTHX) United States $0.097B 0.00
VistaGen Therapeutics (VTGN) United States $0.097B 0.00
Genenta Science S.p.A (GNTA) Italy $0.095B 0.00
Miromatrix Medical (MIRO) United States $0.093B 0.00
CytomX Therapeutics (CTMX) United States $0.093B 0.00
2seventy Bio (TSVT) United States $0.093B 0.00
DiaMedica Therapeutics (DMAC) United States $0.093B 0.00
Eton Pharmaceuticals (ETON) United States $0.091B 35.40
Longboard Pharmaceuticals (LBPH) United States $0.090B 0.00
MediciNova (MNOV) United States $0.089B 0.00
Werewolf Therapeutics (HOWL) United States $0.089B 0.00
Annovis Bio (ANVS) United States $0.087B 0.00
BioAtla (BCAB) United States $0.085B 0.00
BRIACELL THERAP (BCTX) Canada $0.085B 0.00
Curis (CRIS) United States $0.084B 0.00
Shattuck Labs (STTK) United States $0.083B 0.00
Apollomics (APLM) Taiwan $0.082B 0.00
China Health Industries Holdings (CHHE) China $0.082B 0.00
Adverum Biotechnologies (ADVM) United States $0.082B 0.00
Sagimet Biosciences (SGMT) United States $0.082B 0.00
C4 Therapeutics (CCCC) United States $0.080B 0.00
IO Biotech (IOBT) Denmark $0.077B 0.00
Adagene (ADAG) China $0.077B 0.00
Sangamo Therapeutics (SGMO) United States $0.076B 0.00
ATyr Pharma (LIFE) United States $0.076B 0.00
NKGen Biotech (NKGN) United States $0.076B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Rallybio (RLYB) United States $0.072B 0.00
Trevi Therapeutics (TRVI) United States $0.072B 0.00
Ikena Oncology (IKNA) United States $0.070B 0.00
Kronos Bio (KRON) United States $0.069B 0.00
Ocuphire Pharma (OCUP) United States $0.069B 2.33
Jasper Therapeutics (JSPR) United States $0.069B 0.00
Atara Biotherapeutics (ATRA) United States $0.067B 0.00
Affimed (AFMD) Germany $0.067B 0.00
Cidara Therapeutics (CDTX) United States $0.064B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.064B 0.00
Connect Biopharma Holdings (CNTB) United States $0.063B 0.00
Enzo Biochem (ENZ) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.063B 0.00
Eyenovia (EYEN) United States $0.063B 0.00
Checkpoint Therapeutics (CKPT) United States $0.063B 0.00
NGM Biopharmaceuticals (NGM) United States $0.062B 0.00
Bionano Genomics (BNGO) United States $0.062B 0.00
Kezar Life Sciences (KZR) United States $0.061B 0.00
Spero Therapeutics (SPRO) United States $0.060B 12.67
InflaRx (IFRX) Germany $0.060B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.060B 0.00
Alpha Teknova (TKNO) United States $0.060B 0.00
Gyre Therapeutics (GYRE) United States $0.060B 0.00
AVROBIO (AVRO) United States $0.059B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.058B 0.00
Estrella Immunopharma (ESLA) United States $0.058B 0.00
Syros Pharmaceuticals (SYRS) United States $0.058B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Compugen (CGEN) Israel $0.057B 0.00
Spruce Biosciences (SPRB) United States $0.057B 0.00
Solid Biosciences (SLDB) United States $0.057B 0.00
Clene (CLNN) United States $0.056B 0.00
CervoMed (CRVO) United States $0.056B 0.00
Cardiff Oncology (CRDF) United States $0.055B 0.00
Athira Pharma (ATHA) United States $0.055B 0.00
Immunic (IMUX) United States $0.054B 0.00
Coya Therapeutics (COYA) United States $0.053B 0.00
Cara Therapeutics (CARA) United States $0.053B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.052B 0.00
Aligos Therapeutics (ALGS) United States $0.052B 0.00
YS Biopharma (YS) China $0.052B 0.70
Elicio Therapeutics (ELTX) United States $0.052B 0.00
Adicet Bio (ACET) United States $0.051B 0.00
SAB Biotherapeutics (SABS) United States $0.051B 0.00
Beyond Air (XAIR) United States $0.051B 0.00
Turnstone Biologics (TSBX) United States $0.050B 0.00
Dyadic (DYAI) United States $0.049B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.048B 0.00
HOOKIPA Pharma (HOOK) United States $0.048B 0.00
OKYO Pharma (OKYO) $0.047B 0.00
Longeveron (LGVN) United States $0.047B 0.00
Instil Bio (TIL) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Elutia (ELUT) United States $0.042B 0.00
Precision BioSciences (DTIL) United States $0.042B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.042B 0.00
Celularity (CELU) United States $0.041B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.040B 0.00
Kineta (KA) United States $0.040B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.040B 0.00
HCW Biologics (HCWB) United States $0.039B 0.00
Prenetics Global (PRE) Cayman Islands $0.038B 46.71
Theratechnologies (THTX) Canada $0.038B 0.00
Rain Oncology (RAIN) United States $0.038B 0.00
Quince Therapeutics (QNCX) United States $0.038B 0.00
VTv Therapeutics (VTVT) United States $0.037B 0.00
MiNK Therapeutics (INKT) United States $0.036B 0.00
Passage Bio (PASG) United States $0.035B 0.00
Dare Bioscience (DARE) United States $0.035B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.034B 0.00
Cognition Therapeutics (CGTX) United States $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Intensity Therapeutics (INTS) United States $0.034B 0.00
Galena Biopharma (SLS) United States $0.033B 0.00
BeyondSpring (BYSI) United States $0.033B 0.00
NextCure (NXTC) United States $0.033B 0.00
Cyclo Therapeutics (CYTH) United States $0.033B 0.00
Gamida Cell (GMDA) United States $0.033B 0.00
Neoleukin Therapeutics (NLTX) United States $0.033B 0.00
Bolt Biotherapeutics (BOLT) United States $0.032B 0.00
Rezolute (RZLT) United States $0.031B 0.00
Science 37 Holdings (SNCE) United States $0.030B 0.00
Biora Therapeutics (BIOR) United States $0.029B 0.00
UNITY Biotechnology (UBX) United States $0.028B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.028B 0.00
Freeline Therapeutics Holdings (FRLN) United Kingdom $0.027B 0.00
Ocean Biomedical (OCEA) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
IN8bio (INAB) United States $0.027B 0.00
Candel Therapeutics (CADL) United States $0.026B 0.00
Pluri (PLUR) Israel $0.025B 0.00
Xilio Therapeutics (XLO) United States $0.025B 0.00
Portage Biotech (PRTG) $0.024B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Synlogic (SYBX) United States $0.023B 0.00
Purple Biotech (PPBT) Israel $0.023B 0.00
Lumos Pharma (LUMO) United States $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Evaxion Biotech (EVAX) Denmark $0.022B 0.00
Promis Neurosciences (PMN) Canada $0.022B 0.00
NuCana (NCNA) United Kingdom $0.022B 0.00
Femasys (FEMY) United States $0.021B 0.00
Entera Bio (ENTX) Israel $0.020B 0.00
Equillium (EQ) United States $0.020B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.020B 0.00
TFF Pharmaceuticals (TFFP) United States $0.020B 0.00
Cocrystal Pharma (COCP) United States $0.019B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
Aptose Biosciences (APTO) Canada $0.019B 0.00
Sensei Biotherapeutics (SNSE) United States $0.018B 0.00
Moleculin Biotech (MBRX) United States $0.018B 0.00
Lisata Therapeutics (LSTA) United States $0.018B 0.00
Fortress Biotech (FBIO) United States $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.017B 0.00
Forte Biosciences (FBRX) United States $0.017B 0.00
Galecto (GLTO) Denmark $0.017B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.017B 0.00
KALA BIO (KALA) United States $0.016B 0.00
BioAffinity Technologies (BIAF) United States $0.016B 0.00
Lexaria Bioscience (LEXX) Canada $0.015B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.015B 0.00
Orgenesis (ORGS) United States $0.015B 0.00
VBI Vaccines (VBIV) United States $0.015B 0.00
GENPREX (GNPX) United States $0.014B 0.00
PHAXIAM Therapeutics S.A (PHXM) France $0.014B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.014B 0.00
Genetic Technologies (GENE) Australia $0.014B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.014B 0.00
Talis Biomedical (TLIS) United States $0.014B 0.00
Vincerx Pharma (VINC) United States $0.014B 0.00
Mainz Biomed (MYNZ) Germany $0.014B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.014B 0.00
Aprea Therapeutics (APRE) United States $0.014B 0.00
BioCardia (BCDA) United States $0.013B 0.00
Mustang Bio (MBIO) United States $0.013B 0.00
Landos Biopharma (LABP) United States $0.013B 0.00
Aytu BioPharma (AYTU) United States $0.013B 0.00
Telesis Bio (TBIO) United States $0.013B 0.00
Acorda Therapeutics (ACOR) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
GeoVax Labs (GOVX) United States $0.011B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.011B 0.00
Virios Therapeutics (VIRI) United States $0.011B 0.00
CNS Pharmaceuticals (CNSP) United States $0.011B 0.00
Bionomics (BNOX) Australia $0.011B 0.00
ARAVIVE, INC (ARAV) United States $0.011B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Soligenix (SNGX) United States $0.010B 0.00
Edesa Biotech (EDSA) Canada $0.010B 0.00
Aileron Therapeutics (ALRN) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Vaccinex (VCNX) United States $0.009B 0.00
Novogen (KZIA) Australia $0.009B 0.00
ABVC BioPharma (ABVC) United States $0.009B 0.00
GT Biopharma (GTBP) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Trevena (TRVN) United States $0.009B 0.00
Atreca (BCEL) United States $0.009B 0.00
Imunon (IMNN) United States $0.008B 0.00
Notable Labs (NTBL) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
Benitec Biopharma (BNTC) United States $0.008B 0.00
Applied Molecular Transport (AMTI) United States $0.008B 0.00
Alzamend Neuro (ALZN) United States $0.008B 0.00
Galera Therapeutics (GRTX) United States $0.008B 0.00
Evelo Biosciences (EVLO) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Sunshine Biopharma (SBFM) Canada $0.007B 0.00
Prana Biotechnology (ATHE) Australia $0.007B 0.00
RenovoRx (RNXT) United States $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.007B 0.00
Seelos Therapeutics (SEEL) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.007B 0.00
TRACON Pharmaceuticals (TCON) United States $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Cadrenal Therapeutics (CVKD) United States $0.006B 0.00
Chemomab Therapeutics (CMMB) Israel $0.006B 0.00
Cingulate (CING) United States $0.006B 0.00
Windtree Therapeutics (WINT) United States $0.006B 0.00
Palisade Bio (PALI) United States $0.006B 0.04
Avalon GloboCare (ALBT) United States $0.006B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Cyclerion Therapeutics (CYCN) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Biofrontera (BFRI) United States $0.005B 0.00
Bright Minds Biosciences (DRUG) United States $0.005B 0.00
Eterna Therapeutics (ERNA) United States $0.005B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Silo Pharma (SILO) United States $0.005B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.005B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.005B 0.00
Invo BioScience (INVO) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Blue Water Biotech (BWV) United States $0.004B 0.00
Monopar Therapeutics (MNPR) United States $0.004B 0.00
Exicure (XCUR) United States $0.004B 0.27
Artelo Biosciences (ARTL) United States $0.004B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.004B 0.00
First Wave BioPharma (FWBI) United States $0.004B 0.00
NeuBase Therapeutics (NBSE) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Ensysce Biosciences (ENSC) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Atrinsic (PTIX) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Aceragen (ACGN) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Panbela Therapeutics (PBLA) United States $0.003B 0.00
Adial Pharmaceuticals (ADIL) United States $0.003B 0.00
NexImmune (NEXI) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Allarity Therapeutics (ALLR) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.002B 0.00
Dermata Therapeutics (DRMA) United States $0.002B 0.00
Clovis Oncology (CLVSQ) United States $0.002B 0.00
PaxMedica (PXMD) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.11
GRI Bio (GRI) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Kintara Therapeutics (KTRA) United States $0.001B 0.00
Tharimmune (THAR) United States $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
MorphoSys AG (MOR) Germany $0.000B 17.54
ARCA Biopharma (ABIO) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
GH Research (GHRS) Ireland $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00